Loading...
Loading...
India's biotin imports from CHINA total $96.2K across 125 shipments from 15 foreign suppliers. FAPON INTERNATIONAL LIMITED leads with $69.6K in import value; the top 5 suppliers together control 94.1% of this origin. Leading Indian buyers include TULIP DIAGNOSTICS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for biotin — a diversified sourcing base with multiple active suppliers from CHINA.

FAPON INTERNATIONAL LIMITED is the leading Biotin supplier from CHINA to India, with import value of $69.6K across 77 shipments. The top 5 suppliers — FAPON INTERNATIONAL LIMITED, SINO BIOLOGICAL INC, BEIJING KEY-BIO BIOTECH CO LTD, FAPON INTERNATIONAL LIMITED., BEIJING KEY-BIO BIOTECT CO LTD — collectively account for 94.1% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | FAPON INTERNATIONAL LIMITED | $69.6K | 77 | 72.3% |
| 2 | SINO BIOLOGICAL INC | $8.3K | 12 | 8.6% |
| 3 | BEIJING KEY-BIO BIOTECH CO LTD | $6.7K | 4 | 7.0% |
| 4 | FAPON INTERNATIONAL LIMITED. | $4.0K | 10 | 4.2% |
| 5 | BEIJING KEY-BIO BIOTECT CO LTD | $1.9K | 1 | 2.0% |
| 6 | WUHAN BIOLAB-REAGENT BIOTECHNOLOGY CO., LTD | $1.2K | 1 | 1.3% |
| 7 | HANGZHOU BIOEAST BIOTECH | $1.1K | 1 | 1.1% |
| 8 | FAPON INTERNATIONAL | $1.1K | 8 | 1.1% |
| 9 | Beijing KEY-BIO Biotech Co.Ltd. | $954 | 1 | 1.0% |
| 10 | SINO BIOLOGICAL INC. | $387 | 1 | 0.4% |
| 11 | FAPON INTERNATIONAL LTD | $351 | 1 | 0.4% |
| 12 | Sino Biological Inc | $318 | 1 | 0.3% |
| 13 | PIERCE BIOTECHNOLOGY INC | $145 | 1 | 0.2% |
| 14 | M/S. GENSCRIPT BIOTECH (SINGAPORE) PTE LTD | $136 | 1 | 0.1% |
| 15 | PIERCE BIOTECHNOLOGY,INC. | $50 | 2 | 0.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TULIP DIAGNOSTICS PRIVATE LIMITED | $34.1K | 12 | 35.4% |
| 2 | MERIL DIAGNOSTICS PRIVATE LIMITED | $23.0K | 23 | 23.9% |
| 3 | MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED | $12.0K | 16 | 12.4% |
| 4 | KRISHGEN BIOSYSTEMS | $9.0K | 14 | 9.3% |
| 5 | BHAT BIO-TECH INDIA PRIVATE LIMITED | $6.0K | 2 | 6.3% |
| 6 | BHAT BIO TECH INDIA PRIVATE LIMITED | $2.8K | 4 | 2.9% |
| 7 | AVANTOR PERFORMANCE MATERIALS INDIA PRIVATE LIMITE | $2.0K | 7 | 2.0% |
| 8 | IMMUNOSCIENCE INDIA PRIVATE LIMITED | $1.9K | 6 | 2.0% |
| 9 | KARWA ENTERPRISES PRIVATE LIMITED | $1.3K | 3 | 1.3% |
| 10 | KRISHGEN BIOSYSTEMS PRIVATE LIMITED | $1.2K | 1 | 1.3% |
| 11 | MEDSOURCE OZONE BIO MEDICALS PVT LTD | $856 | 3 | 0.9% |
| 12 | IMMUNOSCIENCE INDIA PVT. LTD. | $760 | 6 | 0.8% |
| 13 | Q-LINE BIOTECH PRIVATE LIMITED | $596 | 2 | 0.6% |
| 14 | MEDSOURCE OZONE BIO MEDICALS PRIVATE LIMITED | $480 | 7 | 0.5% |
| 15 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $195 | 3 | 0.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Biotin suppliers from CHINA to India include FAPON INTERNATIONAL LIMITED, SINO BIOLOGICAL INC, BEIJING KEY-BIO BIOTECH CO LTD. The leading supplier is FAPON INTERNATIONAL LIMITED with import value of $69.6K USD across 77 shipments. India imported Biotin worth $96.2K USD from CHINA in total across 125 shipments.
India imported Biotin worth $96.2K USD from CHINA across 125 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Biotin sourced from CHINA include TULIP DIAGNOSTICS PRIVATE LIMITED, MERIL DIAGNOSTICS PRIVATE LIMITED, MEDSOURCE OZONE BIOMEDICALS PRIVATE LIMITED. The largest buyer is TULIP DIAGNOSTICS PRIVATE LIMITED with $34.1K in imports across 12 shipments.
The total value of Biotin imports from CHINA to India is $96.2K USD, across 125 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
125 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists